Arti Rajendra Gogri sold 1,33,564 shares of Aarti Pharmalabs for ₹10.94 Cr at ₹818.77 apiece in an open-market sale, reducing their stake from 0.50% to 0.35%.
A pharmaceutical and nutraceutical manufacturer, Aarti Pharmalabs produces active pharmaceutical ingredients and finished dosage forms for domestic and international markets. The company specializes in contract manufacturing and custom synthesis services across multiple therapeutic segments including oncology, cardiology, and gastroenterology. Incorporated in 2019, it operates manufacturing facilities designed to meet stringent regulatory standards for pharmaceutical production and quality assurance.
